1. Guidance for the safe switching of warfarin to direct oral anticoagulants (DOACs) for patients with non-valvular AF and venous thromboembolism (DVT/PE) during the coronavirus pandemic;Williams;Royal College of General Practitioners and British Society of Haematology,2020
2. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH;Kaatz;J. Thromb. Haemost.,2015
3. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients;Schulman;J. Thromb. Haemost.,2005
4. Public Health England. COVID-19 - investigation and initial clinical management of possible cases (updated 27/4/2020). https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection#criteria. Updated Accessed May 12, 2020.